Clinical Trials

Clinical trials at APDerm give patients access to innovative treatments, including investigational medications and technologies that may not be available elsewhere. We focus on real-world use of approved therapies and the evaluation of new options for patients—especially those whose conditions have not improved with conventional treatments.

Ongoing Studies

  • Atopic Dermatitis

    Phase IV

    Post-approval research evaluating treatment effectiveness and safety.

  • Prurigo Nodularis

    Phase IV

    Post-approval research evaluating treatment effectiveness and safety.

  • Severe Alopecia Areata (Adolescents)

    Phase III

    Investigational therapy for adolescent patients.

Upcoming Studies

  • Atopic Dermatitis

    Phase III

    Investigational therapy for moderate-to-severe disease.

  • Acne Vulgaris

    Phase II

    Investigational therapy for moderate-to-severe disease.

  • Hidradenitis Suppurativa

    Phase III

    Investigational therapy for moderate-to-severe disease.

Background media

Enroll to Participate in a Clinical Trial

This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
Submit

If you are interested in learning more about our research, please contact [email protected] for more information.

Banner media

Advancing Dermatology Through Clinical Trials

Contact us media

Your Family Deserves the Best Care Book an Appointment

Your skin health matters, so don’t delay. Our clinicians look forward to treating you and your family at one of our local New England practices.

Find Your Nearest APDerm Center
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at 978-849-7582.
Schedule Appointment